Table 3 Summary GWAS statistics from the PGC bipolar disorder GWAS at 28 loci and differential expression of the “little” exon by genotype

From: Elevated expression of a minor isoform of ANK3 is a risk factor for bipolar disorder

#

Single nucleotide polymorphism

PGC 2011 BD GWAS

Norwegian sample (eQTL test)

 

dbSNP RSID

Position (hg19: chr10)

Major allele

Minor allele

G1K European MAF

P-value

OR (minor)

MAF

All samples (n=705)

Excl.carriers of rs41283526*G (n=691)

         

FC

p-value

FC

p-value

1

rs2288359a

61902023

C

T

0.059

1.2E–01

1.09

0.064

1.09

5.3E–04

1.08

1.2E–03

2

rs41283526a

61905727

A

G

0.016

3.6E–04b

0.25b

0.013

0.54

1.2E–08

NAc

NAc

3

rs12357972a

61907907

T

C

0.048

5.5E–03

1.16

0.051

1.08

3.0E–03

1.07

5.8E–03

4

rs16914810

61913414

T

C

0.047

2.1E–02

1.98

0.05

1.08

2.0E–03

1.07

4.0E–03

5

rs2393614a

61915955

C

T

0.319

9.6E–02

1.05

0.358

1.04

2.5E–02

1.02

8.0E–02

6

rs10509125a

61926866

A

C

0.394

2.5E–02

1.06

0.429

1.08

4.9E–05

1.06

6.3E–04

7

rs10761473

62060382

C

G

0.078

5.6E–09

1.36

0.057

1.01

3.9E–01

1.00

5.1E–01

8

rs10509129

62071041

G

T

0.047

5.8E–09

1.36

0.041

1.04

1.3E–01

1.03

1.9E–01

9

rs1380459

62097331

C

T

0.070

3.3E–09

1.36

0.052

1.03

1.2E–01

1.02

1.8E–01

10

rs10994308

62098952

G

A

0.070

3.8E–09

1.36

0.052

1.03

1.2E–01

1.02

1.8E–01

11

rs10821736a

62105053

C

T

0.070

1.3E–09

1.36

0.052

1.04

8.6E–02

1.03

1.3E–01

12

rs10821745a

62136206

T

G

0.069

2.3E–09

1.35

0.054

1.04

5.7E–02

1.03

9.2E–02

13

rs10994322a

62136279

C

T

0.069

6.7E–09

1.35

0.054

1.04

5.7E–02

1.03

9.2E–02

14

rs4948412

62146576

T

C

0.068

5.3E–09

1.35

0.054

1.04

5.7E–02

1.03

9.2E–02

15

rs3808943

62151015

C

T

0.069

4.7E–09

1.35

0.056

1.04

5.8E–02

1.03

9.4E–02

16

rs10821748

62152938

G

C

0.071

4.4E–08

1.32

0.054

1.04

5.7E–02

1.03

9.2E–02

17

rs12416380

62156154

A

G

0.069

7.5E–09

1.35

0.054

1.04

5.7E–02

1.03

9.2E–02

18

rs4948417a

62161618

A

G

0.068

5.5E–09

1.35

0.054

1.04

5.7E–02

1.03

9.2E–02

19

rs10994336a

62179812

C

T

0.073

4.0E–09

1.35

0.052

1.04

9.8E–02

1.03

1.5E–01

20

rs10994338a

62181128

C

T

0.073

6.7E–09

1.34

0.052

1.04

9.8E–02

1.03

1.5E–01

21

rs9633553

62274737

T

G

0.075

5.5E–10

1.35

0.054

1.05

7.0E–02

1.04

1.1E–01

22

rs10994397a

62279124

C

T

0.075

5.5E–10

1.35

0.054

1.05

7.0E–02

1.04

1.1E–01

23

rs12412135

62282834

C

T

0.094

4.2E–08

1.27

0.074

1.05

1.5E–02

1.05

1.9E–02

24

rs1938540

62294814

C

T

0.079

1.9E–09

1.33

0.054

1.06

2.5E–02

1.05

4.3E–02

25

rs10821792a

62298616

C

T

0.079

2.0E–09

1.32

0.054

1.06

2.5E–02

1.05

4.3E–02

26

rs1938526

62300383

A

G

0.079

1.9E–09

1.32

0.054

1.06

2.5E–02

1.05

4.3E–02

27

rs10994415

62322034

T

C

0.074

7.0E–10

1.31

0.075

1.04

8.1E–02

1.03

1.4E–01

28

rs2154393

62326687

C

T

0.074

3.7E–09

1.29

0.076

1.04

7.2E–02

1.03

1.3E–01

  1. Fold change (FC) is the ratio of the mean “little” exon expression for minor allele carriers to the mean for non-carriers. Tests are one-sided Wilcoxon test of higher expression of the little exon in minor allele carriers vs. non-carriers (with the exception of rs41283526, where we test lower expression in carriers)
  2. p-values are uncorrected for multiple testing and sites significant at 5% are highlighted in bold
  3. Samples used in the differential expression tests (eQTL test) are either all samples for which genotypes and expression are available (n = 705) or excluding those carrying the minor allele at rs41283526 (n = 691)
  4. MAF in Norwegian sample is based on 1167 genotyped samples. Horizontal lines delineate haploblocks as determined by four gametes method on the Norwegian sample
  5. MAF minor allele frequency, G1K 1000 genomes project (503 European individuals in G1K)
  6. aIndicates directly genotyped SNP (as opposed to imputed)
  7. bSNP minor allele frequency was too low to be genotyped or imputed with confidence in PGC GWAS. Instead, we include here the results for the Norwegian BD sample for comparison with the PGC ORs
  8. cNot available because of the exclusion of samples carrying rs41283526*G